#
Recal D
  • Professionals
  • FDA PI

Recal D

Generic name:calcium carbonate, cholecalciferol, magnesium oxide, boric acid, folic acid, pyridoxine hydrochloride and cyanocobalamin
Dosage form: chewable wafer
Drug class:Vitamin and mineral combinations

Medically reviewed by Drugs.com. Last updated on Mar 22, 2022.

Disclaimer: This drug has not been found by FDA to be safe and effective, and this labeling has not been approved by FDA. For further information about unapproved drugs, click here.

INDICATIONS AND USAGE:

Recal D Wafers are indicated to help, along with diet, the treatment of calcium deficiency, skeletal weakness and osteoporosis. Recal D Wafers supplementation may be beneficial to individuals who have an insufficient dietary intake of the nutrients in this formulation. Calcium and vitamin D supplementation may be useful in both preventing and treating osteoporosis. Vitamin D supplementation may be beneficial to those who are institutionalized and/or have reduced exposure to sunlight. Folic acid, vitamin B6 and vitamin B12 may help reduce the risk of cardiovascular disease by lowering blood levels of homocysteine. If dietary intake of calcium is inadequate, patients currently taking bisphosphonates for osteoporosis treatment should be instructed to take calcium and vitamin D daily.

DOSAGE AND ADMINISTRATION:

Chew one wafer twice daily or as prescribed by a physician.

DOSAGE FORMS AND STRENGTHS:

Recal D Wafers are supplied in bottles of 60 wafers, NDC 68032-270-60 and are brown, round shaped wafers, debossed on scored side with “RE 270.”

CONTRAINDICATIONS:

Recal D Wafers are contraindicated in patients with hypersensitivity to any of its ingredients. Calcium and vitamin D supplementation is contraindicated in those with hypercalcemia or conditions that may lead to hypercalcemia and those who form calcium containing stones are generally advised not to take supplemental calcium. Used together, iron and calcium may inhibit the absorption of iron. Concurrent use of quinolones or tetracyclines with calcium may decrease the absorption of these medications. Folic acid is contraindicated in patients with untreated and uncomplicated pernicious anemia, and in those with anaphylactic sensitivity to folic acid. The use of folic acid doses above one milligram per day may precipitate or exacerbate the neurological damage of vitamin B